Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Jun;71(6):1787–1795. doi: 10.1172/JCI110934

Beta adrenergic receptors in lymphocytes and granulocytes from patients with cystic fibrosis.

P B Davis, L Dieckman, T F Boat, R C Stern, C F Doershuk
PMCID: PMC370384  PMID: 6306054

Abstract

Intact lymphocytes from patients with cystic fibrosis (CF) produce significantly (P less than 0.001) less adenosine 3':5' cyclic monophosphate (cAMP) than normal lymphocytes in response to isoproterenol (10(-8)-10(-4) M), although the basal cAMP content and the response to prostaglandin E1 are normal. Obligate heterozygotes for CF have significantly (P less than 0.005) reduced cAMP response to isoproterenol as well, suggesting a genetic component in the beta adrenergic deficiency in CF. The number of beta adrenergic receptors, as determined by equilibrium binding of [3H]dihydroalprenolol to lymphocyte particulates, is the same in normal lymphocytes (969 +/- 165 receptors/cell) and lymphocytes from patients with CF (1,333 +/- 263 receptors/cell). Binding properties of the receptor for both antagonist and agonist, as assessed by KD for dihydroalprenolol and Ki for (-)-isoproterenol, are also normal in the CF lymphocytes. Similarly, in granulocytes from patients with CF, the cAMP response to isoproterenol (10(-8)-10(-4) M) is significantly reduced compared with healthy controls (P less than 0.03), as is the response of granulocytes from obligate heterozygotes (P less than 0.05). Again, the basal cAMP levels and the response to prostaglandin E1 are normal. The number of beta adrenergic receptors, as determined by equilibrium binding of [3H]dihydroalprenolol to granulocyte particulates, was the same in normal (1,462 +/- 249 receptors/cell) and CF (1,621 +/- 221 receptors/cell) preparations. Binding properties of the receptor for both agonist and antagonist, as assessed by KD for dihydroalprenolol and Ki for isoproterenol, are normal in CF granulocyte particulates. The lymphocyte and granulocyte beta adrenergic defect in CF cannot be explained by abnormalities of the beta adrenergic receptor or of adenylate cyclase itself. Receptor-cyclase coupling is the most likely site of the heritable beta adrenergic defect in CF.

Full text

PDF
1787

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons R. D., Nies A. S., Gal J., Hegstrand L. R., Molinoff P. B. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May;65(5):949–957. doi: 10.1172/JCI109781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arkesteijn C. L. A kinetic method for serum 5'-nucleotidase using stabilised glutamate dehydrogenase. J Clin Chem Clin Biochem. 1976 Mar;14(3):155–158. doi: 10.1515/cclm.1976.14.1-12.155. [DOI] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  4. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  7. DIXON T. F., PURDOM M. Serum 5-nucleotidase. J Clin Pathol. 1954 Nov;7(4):341–343. doi: 10.1136/jcp.7.4.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DOERSHUK C. F., MATTHEWS L. W., TUCKER A. S., NUDLEMAN H., EDDY G., WISE M., SPECTOR S. A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROGRAM FOR PATIENTS WITH CYSTIC FIBROSIS. J Pediatr. 1964 Nov;65:677–693. doi: 10.1016/s0022-3476(64)80152-9. [DOI] [PubMed] [Google Scholar]
  9. Davies A. O., Lefkowitz R. J. Corticosteroid-induced differential regulation of beta-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab. 1980 Sep;51(3):599–605. doi: 10.1210/jcem-51-3-599. [DOI] [PubMed] [Google Scholar]
  10. Davis P. B., Braunstein M., Jay C. Decreased adenosine 3':5'-monophosphate response to isoproterenol in cystic fibrosis leukocytes. Pediatr Res. 1978 Jun;12(6):703–707. doi: 10.1203/00006450-197806000-00005. [DOI] [PubMed] [Google Scholar]
  11. Davis P. B., Laundon S. C. Adenylate cyclase in leukocytes from patients with cystic fibrosis. J Lab Clin Med. 1980 Jul;96(1):75–84. [PubMed] [Google Scholar]
  12. Davis P. B., Shelhamer J. R., Kaliner M. Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis. N Engl J Med. 1980 Jun 26;302(26):1453–1456. doi: 10.1056/NEJM198006263022605. [DOI] [PubMed] [Google Scholar]
  13. Farfel Z., Brickman A. S., Kaslow H. R., Brothers V. M., Bourne H. R. Defect of receptor-cyclase coupling protein in psudohypoparathyroidism. N Engl J Med. 1980 Jul 31;303(5):237–242. doi: 10.1056/NEJM198007313030501. [DOI] [PubMed] [Google Scholar]
  14. Fraser J., Nadeau J., Robertson D., Wood A. J. Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest. 1981 Jun;67(6):1777–1784. doi: 10.1172/JCI110217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Galant S. P., Allred S. Binding and functional characteristics of beta adrenergic receptors in the intact neutrophil. J Lab Clin Med. 1981 Aug;98(2):227–237. [PubMed] [Google Scholar]
  16. Galant S. P., Norton L., Herbst J., Wood C. Impaired beta adrenergic receptor binding and function in cystic fibrosis neutrophils. J Clin Invest. 1981 Jul;68(1):253–258. doi: 10.1172/JCI110241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Harden T. K., Su Y. F., Perkins J. P. Catecholamine-induced desensitization involves an uncoupling of beta-adrenergic receptors and adenylate cyclase. J Cyclic Nucleotide Res. 1979;5(2):99–106. [PubMed] [Google Scholar]
  18. Lake C. R., Davis P. B., Ziegler M., Kopin I. J. Electrolytes and norepinephrine levels in blood of patients with cystic fibrosis. Clin Chim Acta. 1979 Mar 1;92(2):141–146. doi: 10.1016/0009-8981(79)90107-4. [DOI] [PubMed] [Google Scholar]
  19. Lemanske R. F., Jr, Mischler E. H., Farrell P. M., Anderson C., Busse W. W. Analysis of granulocyte beta-adrenergic response in cystic fibrosis: correlation of decreased responsiveness with disease severity. Am Rev Respir Dis. 1981 Jun;123(6):622–626. doi: 10.1164/arrd.1981.123.6.622. [DOI] [PubMed] [Google Scholar]
  20. Rodbell M. The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature. 1980 Mar 6;284(5751):17–22. doi: 10.1038/284017a0. [DOI] [PubMed] [Google Scholar]
  21. Williams L. T., Snyderman R., Lefkowitz R. J. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest. 1976 Jan;57(1):149–155. doi: 10.1172/JCI108254. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES